EU Approves New Therapy for HER2-Positive Breast Cancer
Episode 1 min 38s

EU Approves New Therapy for HER2-Positive Breast Cancer

Welcome to Onco Life Centre Podcast. This episode explains a new European approval for adults whose early HER2-positive breast cancer remains after treatment before surgery. We walk through what the decision means, what the trial found, and what to watch for. You'll learn: - What the European Commission approved on 27 October 2026 and who it applies to - What residual disease means and why it signals a higher risk of return - How HER2 status and the HER2 gene shape treatment planning - What...

Community discussion